Hepatitis B infections

BMJ

Volumn 329, Issue 7474, 2004, Pages 1059-1060

  Beeching, Nicholas J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

EDITORIAL; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; PRIORITY JOURNAL; SCREENING; SEROCONVERSION; UNITED KINGDOM; UNIVERSAL IMMUNIZATION; VIRUS CARRIER;

GREAT BRITAIN; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS;

EID: 8544257326     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.329.7474.1059     Document Type: Editorial

References (12)

1. Lavanchy D. Hepatitis B epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97–107.
2. Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int 2004; 19: 95–103.
3. Foundation for Liver Research. Hepatitis B: out of the shadows. London, Foundation for Liver Research, 2004. www.ucl.ac.uk/liver-research/hepatitis-report.pdf (accessed 28 Oct 2004).
4. Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ 2004; 329: 1080–6.
5. Asmuth DM, Nguyen HH, Melcher GP, Cohen SH, Pollard RB. Treatments for hepatitis B. Clin Infect Dis 2004; 39: 1353–62.
6. Department of Health. Hepatitis B in Immunisation against infectious diseases 1996-“the green book.” London: Stationery Office, 1996. www.dh.gov.uk/assetRoot/04/07/30/12/04073012.pdf (accessed 18 Oct 2004).
7. Hahné S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 2004; 29: 211–20.
8. Lamden KH, Kennedy N, Beeching NJ, Lowe D, Morrison CL, Mallinson H, et al. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. J Infect 1998; 37: 260–9.
9. Kretzschmar M, de Wit GA, Smits LJ, van de Laar MJ. Vaccination against hepatitis B in low endemic countries. Epidemiol Infect 2002; 128: 229–44.
10. Banatvala JE, van Damme P. Hepatitis B vaccine-do we need boosters? J Viral Hepat 2003; 10: 1–6.
11. Karayiannis P, Main J, Thomas HC. Hepatitis vaccines. Br Med Bull 2004; 70: 29–49.
12. Department of Health. Hepatitis B infected health care workers and oral antiviral therapy: consultation paper on implementing expert advice about a limited relaxation of restrictions on hepatitis B infected health care workers. London: Stationery Office. 2004. www.dh.gov.uk/assetRoot/04/08/64/62/04086462.pdf (accessed 18 Oct 2004).